Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy

Hoffmann, E.; Toepell, A.; Peter, A.; Boeke, S.; De-Colle, C.; Steinle, M.; Niyazi, M.; Gani, C.

dc.contributor.author	Steinle, Marc
dc.contributor.author	Hoffmann, Elgin
dc.contributor.author	Niyazi, Maximilian
dc.contributor.author	Böke, Simon
dc.contributor.author	Gani, Cihan
dc.contributor.author	De-Colle, Chiara
dc.contributor.author	Peter, Andreas
dc.contributor.author	Toepell, Andreas
dc.date.accessioned	2026-02-03T09:42:17Z
dc.date.available	2026-02-03T09:42:17Z
dc.date.issued	2025
dc.identifier.issn	0179-7158
dc.identifier.uri	http://hdl.handle.net/10900/174678
dc.language.iso	en	de_DE
dc.publisher	Heidelberg : Springer Heidelberg	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00066-024-02287-7	de_DE
dc.subject.ddc	610	de_DE
dc.title	Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_02653
utue.publikation.seiten	679-686	de_DE
utue.personen.roh	Hoffmann, E.
utue.personen.roh	Toepell, A.
utue.personen.roh	Peter, A.
utue.personen.roh	Boeke, S.
utue.personen.roh	De-Colle, C.
utue.personen.roh	Steinle, M.
utue.personen.roh	Niyazi, M.
utue.personen.roh	Gani, C.
dcterms.isPartOf.ZSTitelID	Strahlentherapie und Onkologie	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	201	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE